Brief Interventions for Drop-out Re-engagement

Substance Abuse Clinical Trial

Official title:

Adaptive Brief Interventions for Drop-out Re-engagement

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00350571
• Other study ID #: 101010101
• Secondary ID: 5P50DA009241-120
• Status: Completed
• Phase: Phase 1
• First received: July 7, 2006
• Last updated: September 16, 2014
• Start date: November 2004
• Est. completion date: November 2009

Study information

• Verified date: September 2014
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.

Description:

We propose a 5-year Stage I behavioral therapy development study to: 1) prospectively evaluate risk factors for premature drop-out from outpatient treatment; 2) develop and test a manual of single session phone-and office-based interventions to re-engage these individual in treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 299
• Est. completion date: November 2009
• Est. primary completion date: November 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• admission to outpatient treatment

Exclusion Criteria:

• need for hospitalization

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Substance Abuse

Intervention

Behavioral:
• brief (behavioral therapy)
up t 3 sessions of phone or office based counseling sessions to promote re-engagement in treatment.
• Drop out re-engagement motivational intervention
Up to 3 phone or office based counseling sessions to promote reengagement in treatment
• standard care follow up
routine counselor phone calls and letters

Locations

Country	Name	City	State
United States	APT Foundation	New Haven	Connecticut
United States	Connecticut Mental Health Center	New Haven	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	retention into outpatient treatment		4, 8, 12, 24 weeks	No
Secondary	substance abuse		4, 8,12,and 24 weeks	No
Secondary	psychiatric symptoms		4, 8, 12, and 24 weeks	No